Introduction 1
Over the last decade, considerable effort has been made to disentangle the various pathways in 2 which peroxisomes are involved. Evidence abounds that defects in peroxisome biogenesis and β-3 oxidation of fatty acids cause several inherited diseases, which -in most cases -are lethal [1] . 4
Peroxisomes are known to be involved in many aspects of lipid metabolism, including synthesis of 5 bile acids and plasmalogens, synthesis of cholesterol and isoprenoids, α-oxidation and β-oxidation 6 of very-long-straight-or -branched-chain acyl-CoAs. The peroxisomal degradation of straight-7 chain acyl-CoAs by a discrete set of enzymes has been well documented. The β-oxidation of 8 straight-chain acyl-CoAs starts with a reaction catalyzed by acyl-CoA oxidase 1 (Acox1), the rate-9 limiting enzyme of the β-oxidation pathway. This step is followed by two enzymatic reactions 10 carried out by the MFP1/L-bifunctional protein and the MFP2/D-bifunctional protein. The fourth 11 and last step is catalyzed by the peroxisomal 3-ketoacyl-CoA thiolases. 12 Intriguingly, two different peroxisomal 3-ketoacyl-CoA thiolases for very-long-straight-chain fatty 13 acids (thiolase A, ThA, Acaa1a and thiolase B, ThB, Acaa1b, EC:2.3.1.16) have been cloned in 14 rodents, while only one corresponding gene (peroxisomal 3-acetyl-CoA acetyltransferase-1, 15 ACAA1) has been identified in humans [2] [3] [4] . The third peroxisomal thiolase, SCP-2/3-ketoacyl-16
CoA thiolase (SCPx), displays a very broad substrate specificity, including cleavage of 2-methyl 17 branched as well as straight-chain 3-ketoacyl-CoA esters [1, 5, 6] . 18
Targeted disruption of the mouse Acox1 gene has revealed the critical role of this enzyme in 19 hepatocellular proliferation and peroxisome proliferation as well as in the catabolism of very-long-20 chain fatty acids [7, 8] . Peroxisomal acyl-CoA oxidase deficiency and its consequences are also 21 well documented in humans [9] . Two isoforms of ACOX1 (a and b) have been characterized in 22 mouse and man [10] . Vluggens et al. recently studied the respective roles of these isoforms by 23 using adenovirally driven hACOX-1a and hACOX-1b in Acox1 null mice [10, 11] . The hACOX-1b 24 isoform was more effective in reversing the Acox1 null phenotype than the hACOX-1a isoform, 25 illustrating functional differences between these two closely related proteins. Other reports aimed 26 at characterizing the consequences of Mfp-1 (L-PBE) and/or Mfp-2 (D-PBE) deficiencies in mice 1 are also available [12] . While most biochemical parameters remained unaffected by the single 2 deletion of Mfp-1, Mfp-1 deficient mice displayed marked reduction in peroxisome proliferation 3 when challenged with a peroxisome proliferator [13] . The Mfp-2 deficient mice displayed 4 disturbances in bile acid metabolism and in the breakdown of very-long-chain fatty acids. Recently, 5 it was also reported that deletion of Mfp-2 in mice resulted in the combined upregulation of 6 PPARalpha and SREBP-2 target genes in the liver, suggesting a potential cross-talk between the 7 two signalling cascades, orchestrated by MFP-2 [14] . 8
Information about ACAA1 remains fragmentary and only a limited number of studies has been 9 reported so far [4, 15] . The discovery of a young girl with a specific mutation within the ACAA1 10 gene was initially believed to shed some light on the role of ACAA1 in very-long-chain fatty acid 11 catabolism [16] . However, follow-up investigations demonstrated that the true defect was rather at 12 the level of D-bifunctional protein, rendering the impact of ACAA1 in humans uncertain [15] . To 13 date, it is not clear if ACAA1 plays a similar role in humans and rodents, nor whether ACAA1 can 14 be considered as the ortholog of ThA and/or ThB [2] . Hence, in an effort to improve our 15 understanding of the functions of peroxisomal 3-ketoacyl-CoA thiolases, we began by studying the 16 deletion of Thb in mice [17] . 17
As a hypolipidemic fibrate drug, the synthetic peroxisome proliferator Wy14,643 (Wy) causes 18 proliferation of peroxisomes in liver parenchymal cells [18] . In WT mice, Wy administration gives 19 rise to a robust elevation of mitochondrial and peroxisomal fatty acid β-oxidation, hepatocyte 20 hyperplasia and then hepatomegaly, but these effects are not found in PPARα deficient mice [19] . 21
At the molecular level, Wy has been characterized as a potent and selective activator of the nuclear 22 hormone receptor PPARα in humans and rodents [20, 21] . PPARα is well expressed in 23 metabolically active tissues such as hepatic, renal and brown adipose tissue [22] . After binding of 24 Wy, PPARα becomes activated and regulates the expression of a subset of genes commonly 25 referred to as PPARα target genes [23] . Previously, Thb was identified as a gene highly responsive 26 to PPARα agonists [24, 25] . Therefore Thb mRNA levels can be modulated by treatment with 1 peroxisome proliferators (PP). In addition to being crucial for lipid handling, PPARα has been 2 linked to the regulation of genes involved in cell growth, differentiation and inflammation control 3 [26] [27] [28] [29] . Using gene expression profiling combined with northern-blotting or RT-qPCR 4 experiments, it has also been established that the effects of Wy on hepatic gene expression are 5 robust and almost exclusively mediated by PPARα [30, 31] . 6
Since Thb expression is highly activated by PPARα, it can be hypothesized that the effect of Thb 7 deletion would be more pronounced under conditions of PPARα activation. Accordingly, the effect 8 of Thb deletion was studied in WT mice and Thb -/-mice, both treated with Wy for 8 days, and 9 fasted for 6h before sacrifice. The results indicate that ThB inactivation is associated with a modest 10 but statistically significant decrease in peroxisomal palmitate β-oxidation. It is also worth noting 11 that ThB is dispensable for Wy-mediated cell and peroxisome proliferation in the liver. 12 Intriguingly, the Wy-induction of some genes encoding for cholesterol biosynthesis enzymes was 13 altered in Thb -/-mice, suggesting that ThB has a unique and unexpected role in cholesterol 14 metabolism. 15 16 17
Materials and methods 18

Animals 19
Male, pure-bred Sv129 (WT) and Thb -/-mice have been previously described [17] . Mice were kept 20 in normal cages with food and water ad libitum, unless indicated. Mice were routinely fed a 21 standard commercial pellet diet (UAR A03-10 pellets from Usine d'Alimentation Rationnelle, 22
Epinay sur Orge, France, 3.2 kcal/g) consisting (by mass) about 5.1% fat (C16:0 0.89% ; C16:1n-7 23 ±0.09% ; C18:0 ±0.45% ; C18:1n-9 ±1.06%, C18:2n-9 ±1.53% and traces of C18:3n-9). At the 24 time of sacrifice, animals were around 4-5 months old. Unless indicated, male mice in the fasted 25 state were deprived of food for 6h starting at 4:0 pm. Blood was collected via orbital puncture into 26 EDTA tubes. The animal experiments were approved by the animal experimentation committee of 27 the University of Burgundy (protocol number n°1904) and were performed according to European 1 Union guidelines for animal care. 2 3
Chemicals 4
For the purposes of the present work, Wy was obtained from ChemSyn Laboratories (Lenexa, 5 Kansas), Fenofibrate from Sigma, Arabic gum from Merck, qPCR MasterMix Plus for SYBR 6
Green I with fluorescein from Eurogentec, and (1- µl/day) for 14 days. In both cases, these molecules were dispersed into water containing 3% Arabic 12 gum. This protocol was performed daily between 8.00 a.m. and 10.00 a.m. Livers were excised, 13 weighed, snap-frozen in liquid nitrogen, and stored at -80 °C. For the RNA analyses, tissue 14 samples were taken from the same liver lobe in each mouse to avoid variability. 15 16
Peroxisomal and mitochondrial oxidation of (1-14 C) palmitate 17
Peroxisomal and mitochondrial oxidation of (1-14 C) palmitate were measured as described 18
elsewhere [32] . However, instead of quantifying the 14 CO2 radioactivity level, the release of (1-19 14 C) acetyl-CoA and (1-14 C) acetyl-carnitine in perchloric acid was quantified after one cycle of β-20 oxidation. 21 22
Mitochondrial and peroxisomal enzyme assays. 23
Liver homogenates and mitochondrial fractions were prepared as usually described [33] . Livers 24 were homogenized with a Teflon pestle rotating at 300 rpm in a cooled Potter-Elvehjem 25 homogenizer, in 20 volumes of chilled solution of 0.25 M sucrose, 2 mM EGTA, and 10 mM HCl (pH 7.4). Palmitate oxidation rates were measured in two separate media: the first allowed 27 series of alcohol (80%-100%). Finally, liver samples were placed in xylene before being embedded 1 in paraffin. Paraffin sections (4 µm thick) were cut and fixed to polylysine-coated slides. 2
Proliferative activity was then measured by labeling of the Ki-67 antigen, which is expressed in the 3 nuclei of all cells in G1, S, G2, and M phases. After removing paraffin with xylene, sections were 4 re-hydrated in a graded series of ethanol from 100% to 95%. Endogenous peroxidase was blocked 5 with 3°/°° H2O2 in methanol for 10 min. All sections were pre-treated in a microwave oven in a 10 6 mM citrate buffer at pH = 6 for 10 minutes at 100°C. Non-specific binding sites were blocked 7 using 10% goat serum (diluted in PBS 0.1% and triton X-100) before an incubation of 2 h at room 8 temperature. Incubation with anti-Ki-67 (AB9260, Millipore), the primary polyclonal antibody, 9 was then performed, followed by incubation with a goat anti-rabbit IgG secondary antibody (Santa 10 Cruz Biotechnology, sc-2004) . Ki-67 positive cells were visualized by exposing the peroxidase to 11 3,3'-diaminobenzidine hydrochloride chromogen substrate (DAKO, K3467, France) following by 12 counterstaining with hematoxylin. Slides were then washed with deionized water and mounted with 13 a permanent medium (Clearmount mounting solution, Invitrogen Ltd., cat. no. 00-8010). It is also 14 worth noting that all cells in the active phases of the cell cycle stained brown except G0-phase 15 cells, which remained blue. To determine mitotic activity, an average of 4 fields on each slide was 16 analysed per animal (n=3). The Ki-67 labelling index was defined as Ki-67 positive cells/total cells 17 present in the field. 18 19
Plasma metabolites 20
Plasma was initially collected into EDTA tubes via retro-orbital punctures and then centrifuged at 21 4°C (10 min, 6000 rpm). Plasma β-hydroxybutyrate levels were determined using a β-22 hydroxybutyrate-FS kit (Diasys Diagnostic Systems International, France). Plasma free fatty acid 23 levels were evaluated with the NEFA-C kit from WAKO. 24
For lathosterol measurements, plasma was mixed with epicoprostanol, which was used as a control 25 standard. Potassium hydroxide saponification was followed by lipid extraction with hexane. 26
Cholesterol and lathosterol were analyzed in the trimethylsilyl ether state by GC-MS using a 27
Hewlett Packard HP6890 Gas Chromatograph equipped with an HP7683 Injector and an HP5973 1 Mass Selective Detector. 2 3 3.0. RNA isolation and reverse transcription step 4
Liver RNA was extracted with a TRIzol reagent (Invitrogen) using the supplier's instructions. RNA 5 was then further purified (from free nucleotides and contaminating genomic DNA) using RNeasy 6 columns (Qiagen) and DNAse treatment. 1 µg of RNA was used for reverse transcription with 7 iScript Reverse Transcriptase (Bio-rad). 8 9
Oligonucleotide microarray 10
Liver RNA samples, prepared using a TRIzol reagent, were collected from four groups of five 11 mice. One group of 5 WT mice and one group of 5 Thb -/-mice had been treated with Wy, the other 12 two groups (5 WT mice and 5 Thb -/-mice) had not been treated with Wy. An equivalent amount of 13 RNA from each animal (from all four groups) was subsequently pooled. Pooled RNA was further 14 purified using Qiagen RNeasy columns and the quality was verified using an Agilent bioanalyzer 15 2100 (Agilent technologies, Amsterdam, the Netherlands). RNA was judged suitable for array 16 hybridization if the sample showed intact bands corresponding to the 18S and 28S rRNA subunits 17 and no chromosomal peaks. As in a previous study, 10 µg of RNA was used for one cycle of cRNA 18 synthesis (Affymetrix, Santa Clara, USA) [39] . Hybridization, washing and scanning of Affymetrix 19
GeneChip mouse genome 430 2.0 arrays were performed following standard Affymetrix protocols. 20 Fluorimetric data were processed by Affymetrix GeneChip Operating software, and the gene chips 21
were globally scaled to all probe sets with an identical target intensity value. Further analysis was 22 performed using Data Mining Tools (Affymetrix). 23 24
Real-Time Quantitative PCR 25
PCR reactions were performed using the qPCR MasterMix Plus for SYBR Green I with fluorescein 26 (Eurogentec). All PCR reactions were performed with MultiGuard Barrier Tips (Sorenson 27 BioScience, Inc.) and an iCycler PCR machine (Bio-Rad Laboratories). Primers were designed to 1 generate a PCR amplification product of 50-120 bp and were selected following the 2 recommendations provided with the Primer 3 software (http://frodo.wi.mit.edu/cgi-3 bin/primer3/primer3_www.cgi). The specificity of the amplification was verified via melt curve 4 analysis, and the efficiency of PCR amplification was evaluated by a standard curve procedure. The 5 expression of each gene was determined relative to 36B4 as a control gene and the relative gene 6 expression was calculated by using the "delta-delta Ct" quantification method. 7 8
Preparation of liver nuclear extracts 9
Nuclear extracts of liver were prepared following established protocols [40] . 10 
Liver cholesterol 10
About 100 mg of each liver sample was saponified by heating in ethanol-KOH, and then 11 cholesterol was extracted from the saponified solution with hexane. Epicoprostanol (5β-cholestan-12 3α-ol) was used as a standard. After evaporation of hexane, cholesterol was converted to 13 trimethylesters using bis-silyl-trifluoracetamide. Hepatic total cholesterol was subsequently 14 quantified by gas chromatography. To measure cholesterol ester levels, Folch extraction was 15 followed by a silylation step using bis (trimethyl-silyl) trifluoro-acetamide. Free cholesterol 16 concentration was taken to be the difference between total and esterified cholesterol. 17 As previously shown, we found that Thb expression was strongly induced by Wy (Fig. 1a) . 26 Interestingly, Tha expression was higher in Thb -/-mice treated with Wy (Wy-genotype interaction, 27 p=0.046), indicating a possible compensation of the non-expression of the thb gene (Fig. 1a) Fig. 1d ) (Fig. 1c, p=0 .252). To determine whether lack of Thb in mice 9
translates into functional alteration of fatty acid β-oxidation, we measured the rate of peroxisomal 10 β-oxidation of (1-14 C) palmitate, using a liver homogenate from each mouse, both WT and Thb -/-, 11 with and without Wy-treatment (Fig. 1f) . The effect of Thb deletion on the peroxisomal β-12 oxidation of (1-14 C) palmitate was Wy-sensitive (Wy-genotype interaction, p=0.0035), indicating 13 that the deletion of Thb leads to a significant decrease (-31%) in the induction of β-oxidation. Thb 14 inactivation did not affect the production of NADH (which shows the enzymatic activity of Acox1 15 and MFP-1/MFP-2) regardless of the treatment conditions (Fig. 1g) Although Thb deletion caused a reduced rate of peroxisomal palmitate β-oxidation, it had no effect 21 on mitochondrial palmitate oxidation in Wy-treated Thb -/-mice, as shown by the results for the 22 liver homogenate (Fig. 2a) , and for the liver mitochondrial fraction (Fig. 2b) . Consistent with these 23 data, mRNA levels, the activities of Carnitine Palmitoyl Transferase-Iα (CPT-Iα) and of the two 24 mitochondrial markers, MonoAmine Oxidase (MAO) and Citrate Synthase (CS) were similar forWT mice and Thb -/-mice (Table 1 and supplemental Table 1 ). Additionally, circulating free fatty 1 acids (FFA) and β-hydroxybutyrate levels were not significantly altered in Thb -/-mice, both with 2 and without Wy-treatment, or after 24 h-fasting (Table 1) . Taken together, the data show that Thb 3 deletion has very little impact on mitochondrial fatty acid β-oxidation, but that it has a negative 4 effect on peroxisomal fatty acid β-oxidation when mice are metabolically challenged. 5 6 4.3. Wy-treated Thb -/-mice display hepatomegaly similar to WT mice 7
Besides alteration of lipid metabolism, the knockout of the Acox1 gene in mice is widely 8 acknowledged to be associated with major hepatomegaly combined with the absence of 9 peroxisomes [7] . In order to check for the possible impact of Thb deletion on hepatomegaly, the 10 relative liver mass was evaluated for both genotypes. The hepatosomatic index was significantly 11 lower in Thb -/-mice than in WT mice (p=0.0136) (Fig. 3a) . After Wy-treatment, the hepatosomatic 12 index increased in mice of both genotypes, although less in Thb -/-mice, suggesting the possible 13 involvement of ThB in Wy-induced hepatomegaly (Wy-genotype interaction, p=0.004). To further 14 investigate the putative role of ThB in hepatocyte proliferation, the size and number of liver cells 15 were quantified by histological staining using hematoxylin and eosin. Both parameters were 16 affected by Wy: cell numbers decreased and cell surface increased. No genotype effect per se was 17 observed either for cell number (p=0.105) or cell surface (p=0.250) (Fig.3b) , suggesting that Thb 18 deletion has no marked effect on liver cell morphology (Fig. 3c) . To assess the possible 19 implication of ThB in liver cell proliferation, Ki-67 immunohistochemistry was evaluated. Ki-67, a 20 nuclear protein preferentially expressed during all active phases of the cell cycle (G1, S1 and G2) 21 and mitosis, is absent in quiescent cells. The number of Ki-67 positive cells was low for both WT 22
and Thb -/-hepatocytes (Fig.3d) . Consistent with the results from the macroscopic observations, the 23 labelling index from the 8-day exposure of mice to Wy showed a similar increase for both WT and 24
Thb
-/-hepatocytes ( Fig. 3d) indicating that ThB was probably dispensable for cell proliferation in 25 liver. To assess for possible defects in peroxisomal assembly in Thb -/-mice, we performed microscopic 3 studies of liver sections. At light microscopy level, these studies revealed a distinct pattern of 4 numerous, DAB-reactive granules in the hepatocyte cytoplasm of WT mice, with normal 5 peroxisome distribution (Fig. 4a) . Similar peroxisome numbers and distribution were observed in 6
-/-hepatocytes, suggesting that ThB was dispensable for peroxisome biogenesis and 7 proliferation in normal conditions (Fig. 4c) . These results are coherent with similar gene expression 8 of critical peroxins (such as Pex3p, Pex13p and Pex16p) in both WT and Thb -/-mice, indicating 9 that ThB is dispensable for peroxisome biogenesis (supplemental Table 1 ). Wy-treatment caused 10 massive peroxisome proliferation in both WT and Thb -/-hepatocytes ( Fig. 4b, 4d ). This result is 11 consistent with the increased mRNA levels of the PPARα target gene Pex11α observed in both WT 12
and Thb -/-mice ( Fig. 4e ). Taken together, these data indicate that ThB is dispensable for hepatic 13 peroxisome proliferation induced by Wy. 14 Electron microscopy (EM) examination revealed that the liver peroxisomes were more elongated 15 and slightly more numerous in Thb -/-mice than in WT mice ( Fig. 4f, 4h ). These data suggest that 16
Thb deletion does not cause the massive spontaneous peroxisome proliferation that has been 17 observed in the livers of mice deficient for Acox1 [8] . As expected, after Wy-treatment, 18 pronounced peroxisome proliferation was observed in both WT mice and Thb -/-mice. 19 20 21
Thb deletion blunts Wy-mediated upregulation of genes encoding for cholesterol 23 biosynthesis enzymes 24
In order to ascertain whether some metabolic steps are affected by Thb deletion, detailed analysis 1 of the microarray data was performed. In agreement with published data, Wy increased the 2 expression of several genes involved in de novo cholesterol biosynthesis (Fig. 5 and supplemental 3 Table 1 ) [44, 45] . However, this effect was significantly blunted in Thb -/-mice, as shown by RT-4 qPCR (Fig. 6 ). Similar data were collected for fenofibrate (Fig. 7) . These data suggest that ThB 5 may be involved in hepatic cholesterol homeostasis via indirect regulation of the expression of 6 genes encoding for cholesterol biosynthesis enzymes. 7 Since the rate-controlling step in cholesterol biosynthesis is catalyzed by HMG-CoA reductase, we 11 checked whether the induction of Hmg-CoA reductase mRNA by Wy was translated at the protein 12 level. In coherence with the mRNA data, Wy increased HMG-CoA reductase protein content in 13 WT mice, but not in Thb -/-mice ( Fig. 8a) . A similar pattern was observed for two enzymes found in 14 peroxisomes, phosphomevalonate kinase (Pmvk) and mevalonate kinase (Mvk), (Fig. 8a) . 15
However, the pmvk mRNA levels did not reflect the increase in Pmvk at the enzyme level. 16 Therefore, we cannot completely rule out some post-translational modifications by intermediates of 17 the cholesterol and nonsterol isoprene biosynthetic pathways, as previously shown for Mvk [46] . In 18 coherence with an intact PPARα signalling cascade in Thb -/-mice, the nuclear PPARα content was 19 not affected by Thb deletion or by the Wy-treatment (Fig. 8b) . 20
Since genes encoding for cholesterol biosynthesis enzymes are under the direct control of the 21 transcription factor SREBP-2, the Srebp-2 mRNA level was quantified in liver samples of fibrate-22 treated or mock-treated WT and Thb -/-mice. No significant effects of Wy (p=0.792), fenofibrate 23 (p=0.083) or Thb deletion (p=0.71) on hepatic Srebp-2 mRNA were observed (Fig. 8c) . Whatever 24 the genotype and pharmacological activation, the mature nuclear form of SREBP-2 remained 25 constant (Fig. 8c ). These data suggest that the decrease in induction of cholesterol synthesis geneexpression in fibrate-treated Thb -/-mice is probably not the consequence of defects in the 1 maturation process of SREBP-2. 2 3 4.7. The rate of in vivo cholesterol synthesis is reduced by Wy-treatment in both WT mice and 4
Thb
-/-mice. 5
To investigate if the impact of Thb deletion on cholesterol synthesizing genes expression in the liver 6 results in an altered rate of cholesterol synthesis, the plasma lathosterol (5α-cholest-7-en-3β-ol) to 7 cholesterol ratio was determined. This ratio correlates well with the cholesterol balance and has 8 been used as an index of cholesterol biosynthesis [47, 48] . As reported in the literature, the 9 lathosterol/cholesterol ratio measured in the liver and in plasma was significantly reduced by Wy-10 treatment (Wy; p=0.007) and fenofibrate-treatment (FF; p=0.042) in WT mice and in Thb -/-mice 11 ( Fig. 9a and 9c ). In the liver, however, the steady-state hepatic cholesterol (total and free) content 12 remained stable after Wy-treatment in both WT mice and Thb -/-mice, suggesting potential 13 compensatory mechanisms such as a decrease in catabolism of cholesterol to bile acids and/or a 14 decrease in its excretion in the stool ( Fig. 9b and 9d) . 15 16
Discussion 17
We recently reported on the hepatic enrichment of (n-7) and (n-9) mono-unsaturated fatty acids 18 indicating that ThA and/or SCPx/SCP2 thiolase cannot fully compensate for the lack of ThB under 25 conditions of metabolic stress. The role of ThB in the liver becomes crucial for peroxisomal fattyacid oxidation when this function is activated. Even though ThA and ThB share almost complete 1 amino acid similarity (96% identity), they do not necessarily share the same natural substrates and 2 their relative affinity for their substrates could be different [2] . 3
It has previously been reported that the livers of Pex2-or Pex5-deficient mice are devoid of 4 functional peroxisomes [50, 51] . Elsewhere, fibroblasts derived from patients with ACOX1 or 5 MFP2 deficiency have been shown to exhibit a fivefold reduction in peroxisome abundance [52] . 6
However, in some peroxisomal-disorder patients, peroxisome abundance was normal but their form 7 was elongated [53, 54] . Here, we report that Thb -/-mice have slightly elongated peroxisomes, but 8 the mechanism underlying this potentially interesting phenotype remains to be investigated. 9
Mice deficient for peroxisomal oxidative enzymes have fewer peroxisomes, supporting the 10 hypothesis that peroxisomal β-oxidation could partly control peroxisome abundance. Given that 11 reduced peroxisomal β-oxidation was observed in Wy-treated Thb -/-mice, we investigated the 12 function of ThB in this cellular process. Peroxisome abundance was shown to be related to the 13 presence or absence of Wy-treatment and not to genotype. Wy-treated Thb -/-and WT mice both 14 had more peroxisomes than the mock-treated mice, indicating that the role of ThB in peroxisome 15 proliferation is minimal. Pex7-deficient mice have a disrupted peroxisomal receptor for ThB 16 import, but they nevertheless display normal peroxisome assembly, which confirms that 17 peroxisomal ThB is dispensable for peroxisome biogenesis [55] . One possible hypothesis is that 18
ThA and/or SCPX/SCP2 could compensate for the absence of ThB. However, similar Scpx/Scp2 19 mRNA levels were found in WT and Thb -/-mice, making the SCPX/SCP2 hypothesis unlikely. 20
Furthermore, SCPX/SCP2-deficient mice had more peroxisomes in their livers, indicating that 21 SCPX/SCP2 could impede peroxisome proliferation [6] . Elevated Tha mRNA levels in Wy-treated 22
Thb
-/-mice could reflect a response to the previously reported hepatic overload of (n-7) and (n-9) 23 MUFAs ( Fig. 1) [49] . As the substrates and properties of ThA and ThB have still not been 24 completely explored, it is impossible to rule out a mechanism where ThA compensates for the 25 absence of ThB, similar to the compensation observed between MFP-1 and MFP-2 in micedeficient for these genes [56] , (and reviewed in Ref. [5] ), [57] . Thus, the generation of Tha -/-mice 1 would be a positive step in exploring the role of ThA in peroxisome biogenesis, proliferation and 2 function. It could also help to clarify the respective contribution of ThA and ThB to various 3 substrates [56] . 4
In contrast to Pex5 -/-mice, which show a twofold increase in mitochondrial palmitate β-oxidation, 5 mitochondrial palmitate β-oxidation remains unchanged in Thb -/-mice [58] . Furthermore, since 6
Thb deletion appears to have no effect on the structure of the mitochondria as revealed by electron 7 microscopy and on the activity of mitochondrial marker enzymes, we conclude that the biology of 8 the mitochondrion is not dependent on ThB. 9
Previous studies have described an incomplete cholesterol biosynthesis pathway in peroxisomes, 10 with conversion of the peroxisomal acetyl-CoA pool to HMG-CoA. The peroxisomal acetyl-CoA 11 pool produced by β-oxidation represents less than 10% of the total acetyl-CoA in the liver [59] and 12 is channelled preferentially to cholesterol biosynthesis [60] [61] [62] [63] . Cholesterol biosynthesis followed 13 the same pattern in both Thb -/-and WT mice. As the total and free cholesterol content in the liver 14 was also similar in both Thb -/-and WT mice, ThB probably has a limited functional role in this 15 pathway, but compensation by ThA and/or SCPX/SCP2 cannot be ruled out. 16
It is worth recalling that our expression data are in coherence with the existing literature, showing 17 the induction of some genes encoding for cholesterol biosynthesis enzymes after Wy-treatment Almost all the biological effects of Wy on gene expression have been shown to be mediated by the 1 nuclear receptor PPARα [31] . The Wy-induction of genes encoding for cholesterol biosynthesis 2 enzymes has been shown to be dependent on PPARα [44, 45, 71] . Based on these statements, we 3 may speculate that the PPARα signalling cascade may be altered by Thb deletion, explaining at 4 least in part the non-induction of genes encoding for cholesterol biosynthesis enzymes in Wy-5 treated Thb -/-mice. However, the magnitude of Wy-or fibrate-induction in almost all typical 6 hepatic PPARα target genes appears to remain at least the same in Thb -/-mice, arguing against this 7 possibility ( Fig. 1d and supplemental Fig. 2a and 2b) In our previous comparative analysis of liver and plasma fatty acid composition, we found a 23 reduction in DHA (Docosahexaenoic acid, C22:6(n-3), a potent natural activator of PPARα in vivo) 24 in Wy-treated Thb -/-mice, [31, 49] . There was also a reduction in hepatic arachidonic acid 25 (C20:4(n-6)), a natural agonist for the Retinoid X Receptor, in Wy-treated Thb -/-mice [49, 74] . 1 Furthermore, recent data have also indicated that C16:1(n-7) decreases activation of the PPARα 2 target gene in the liver [75] . The amount of C16:1(n-7) is significantly increased in the livers of 3 Wy-treated Thb -/-mice. Changes in the availability of this metabolite in Thb -/-mice may therefore 4 decrease the Wy-induction of cholesterologenic genes by selectively modulating receptor-5 coregulator interactions. 6
Finally, it should be emphasized that Wy-treated Thb -/-mice displayed enrichment of some (n-7) 7 and (n-9) MUFAs in the liver, as the probable consequence of higher Stearoyl-CoA Desaturase-1 8 (SCD1) activity [49] . Recent findings indicate that changes in the hepatic fatty acid composition of 9 the products of SCD1 modulate free cholesterol biosynthesis through a mechanism that implies 10 endoplasmic reticulum (ER) stress [76, 77] . While we cannot completely rule out a role for ER 11 stress in the dysregulation of SREBP-2 target genes by Wy in Thb -/-mice, this explanation appears 12 very unlikely because deleting the Thb gene in mice did not affect the expression pattern of the 13 main genes involved in the emergence of ER stress, as revealed by DNA arrays (data not shown). 14 To conclude, our data suggest that ThB plays a minor role in peroxisome biogenesis and 15 proliferation in the liver. The present work also suggests that under certain conditions of metabolic 16 stress, ThB may contribute to the indirect regulation by activated PPARα of SREBP-2 target gene 17 expression. Like other studies on MFP-2 and Pex2p, our data strengthen the notion that defects in 18 peroxisomal enzymes impact on the mRNA levels of genes encoding for cholesterol biosynthesis 19 enzymes in the liver [14, 78] . There may possibly be molecular and biochemical mechanisms to 20 explain our observations and these avenues should therefore be explored by direct experimentation 21 in the future. the end of the pharmacological intervention, the animals were fasted (starting at 4 a.m) for 6 hours 30 before sacrifice a) Liver RNA (5 animals were used for each condition) was isolated and RT-qPCR 31 was performed. Gene expression levels from the animals receiving vehicle only were set at 1. Thb: 32 peroxisomal 3-ketoacyl-CoA thiolase B ; Tha: peroxisomal 3-ketoacyl-CoA thiolase A b) Western 33 blot analysis of PTL (anti-peroxisomal 3-ketoacyl-CoA thiolase A and B proteins) in liver protein 34 extracts from five animals. β-actin was used as a loading control marker c) Liver RNA was isolated 35 and RT-qPCR was performed (From 6 to 20 animals were used per condition). Gene expression 36 levels from the animals receiving vehicle only were set at 1. Acox 1: peroxisomal Acyl-CoA 37 oxidase 1; Mfp-1: Multifunctional protein 1; Scpx/Scp2 thiolase: Sterol carrier protein x/2 thiolase; 38
Values are expressed as mean ± SEM. See supplemental data, Table 2 for primer sequences. d)Western blot analysis of Acox1 in liver protein extracts from five animals. β-actin was used as a 1 loading control marker e) Peroxisomal (1-14 C) palmitate β-oxidation and f) NADH production were 2 quantified in vitro using whole liver homogenates from WT and Thb -/-mice (n=3) Values are 3 expressed as mean ± SEM. Statistically significant differences were calculated using a two-way 4 ANOVA for genotype (G), Wy14,643 (Wy) and the interaction between the two parameters (I). prominent after Wy-treatment in WT and Thb -/-mice (e) Liver RNA was isolated and RT-qPCR 7 was performed (n =6). Gene expression levels from the animals receiving vehicle only were set at 8 1. Statistically significant differences were calculated using a two-way ANOVA for genotype (G), 9
Wy14,643 (Wy) and the interaction between the two parameters (I). Pex11α: Peroxisomal 10 biogenesis factor 11α ; (f-i) Representative electron micrographs of mouse-liver sections without 11 treatment (f,h) and after Wy-treatment (g,i) . Note the presence of peroxisomes with a slightly 12 elongated shape (see arrows) in h in contrast to the rounded shapes in f. Glycogen rosettes, specific 13 for hepatic parenchyma were present in many cells. M: Mitochondria. 14 15 (30mg/kg of body weight, 8 days), or left untreated. All animals were fasted for 6h prior to 3 sacrifice. Liver RNA was isolated and RT-qPCR was performed. Gene expression levels from the 4 animals receiving vehicle only were set at 1. Hmgcs1 : cytosolic 3-hydroxy-3-methylglutaryl 5 coenzyme A (HMG-CoA) synthase-1, Hmgcr : microsomal 3-hydroxy-3-methylglutaryl coenzyme 6
A (HMG-CoA) reductase, Mvk: mevalonate kinase, Pmvk: phosphomevalonate kinase, 7 mvd: mevalonate decarboxylase, Fdps: farnesyl diphosphate synthase, Fdft1: farnesyl-diphosphate 8 farnesyltransferase-1, Sqls: squalene synthase, sqle: squalene epoxidase, Lss: lanosterol synthase, 9
Cyp51: sterol 14 alpha-demethylase, Nsdhl: NAD(P) dependent steroid dehydrogenase-like, Sc5d: 10 sterol-C5-desaturase, Dhcr7: 7-dehydrocholesterol reductase. Error bars represent ± SEM. 11 Statistically significant differences were calculated using a two-way ANOVA for genotype (G), 12
Wy14,643 (Wy) and the interaction between the two parameters (I). See supplemental data, Table 2  13 for primer sequences. 14 15 Pparα : peroxisome proliferator-activated receptor alpha, FF: Fenofibrate. Statistically significantdifferences were calculated using a two-way ANOVA for genotype (G), fenofibrate (FF) and the 1 interaction between the two parameters (I). See supplemental data, Table 2 
-/-mice (30mg/kg of body weight, 8 days) and fasted for 6h prior to sacrifice. Analyses for 6 mouse HMG-CoA reductase, Mvk and Pmvk protein content were conducted by Western blotting, 7 using polyclonal antibodies. There were 5 animals per group except for the WT group (n=10). 8
Molecular mass sizes are given in kDa. Quantification of bands relative to β-actin controls is given 9 under each picture (b) Western blot analysis of PPARα was performed on nuclear extracts from the 10 livers of five animals. Cellular lysates of COS-7 cells transfected with the expression vector pSG5 11
PPARα were used as a positive control. Histone H1 was used as a loading control marker (c) WT 12 (n=5) and Thb -/-(n=5) mice were treated with Wy for 8 days or left untreated. All animals were 13 fasted for 6h prior to sacrifice. Liver RNA was isolated and RT-qPCR was performed for Srebp-2. 14 Statistically significant differences were calculated using a two-way ANOVA for genotype (G), Error bars represent ± SEM. Statistically significant differences were calculated using a two-way 2 ANOVA for genotype (G), Wy14, 643 (Wy) and the interaction between the two parameters (I). and fasted for 6h prior to sacrifice. Liver RNA was isolated and RT-qPCR was performed. Five to 18 eight animals were used for each condition. Gene expression levels from the animals receiving 19 vehicle only were set at 1. See supplemental 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37 1  2  3  4  5  6 Fidaleo et al., Figure 3 
